A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma
Clinical trial NCT00140049 · COMPLETED
Trial details
- NCT number
- NCT00140049
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.